Sanofi discontinues C. difficile vaccine

Sanofi (Euronext:SAN; NYSE:SNY) discontinued development of its late-stage Clostridium difficile vaccine (ACAM-CDIFF) after an interim analysis by the trial's IDMC concluded that the candidate

Read the full 245 word article

User Sign In